Predictive Signature of Benralizumab Response
- Status
- RECRUITING
- Phase
- PHASE4
Clinical Trials Related to Severe Asthma
Related studies linked through entity extraction aliases.
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Phenotyping Circulating and Lung Resident Eosinophils in Severe Asthma (P-CLESA)
- Status
- UNKNOWN
- Phase
- N/A
National Survey on Care Pathway and Quality of Life in Patients With Severe Asthma According to Their Phenotype.
- Status
- UNKNOWN
- Phase
- N/A
Deployment o the Multidisciplinary Prospective Cohort Imminent
- Status
- RECRUITING
- Phase
- NA
ChAracterisation of ItaliaN Severe Uncontrolled Asthmatic patieNts Key Features When Receiving Benralizumab
- Status
- COMPLETED
- Phase
- N/A
Patient-reported Outcomes in Real-world Use of Benralizumab in Patients With Severe Eosinophilic Asthma in Belgium
- Status
- COMPLETED
- Phase
- N/A
Benralizumab in the Treatment of Patients With Severe Asthma With ABPA
- Status
- WITHDRAWN
- Phase
- PHASE4
Long-term Safety of Tezepelumab in Japanese Subjects With Inadequately Controlled Severe Asthma
- Status
- COMPLETED
- Phase
- PHASE3
International Severe Asthma Registry: Canadian Cohort
- Status
- RECRUITING
- Phase
- N/A
National Validation and Sensitivity to Change of the SAQ
- Status
- COMPLETED
- Phase
- N/A
Dupilumab for Severe Asthma in a Real Life Setting
- Status
- COMPLETED
- Phase
- N/A
Swiss Severe Asthma Register
- Status
- RECRUITING
- Phase
- N/A
Prevalence of the Eosinophilic Phenotype Among Severe Asthma Patients
- Status
- COMPLETED
- Phase
- N/A
BRazilian Asthmatics Patients EOSinophilic Profile (BRAEOS)
- Status
- COMPLETED
- Phase
- N/A
Type 2 Innate Lymphoid Cells in Severe Pediatric Asthma
- Status
- WITHDRAWN
- Phase
- N/A
Characterisation of Patients With Severe Asthma in Primary and Secondary Care Settings in Europe Reported to be Eligible for Biological Therapy
- Status
- COMPLETED
- Phase
- N/A
Russian Severe Asthma Registry
- Status
- UNKNOWN
- Phase
- N/A
Clinical, Inflammatory and Functional Evaluation of a Population of Severe and Obese Asthmatics: Follow up
- Status
- UNKNOWN
- Phase
- NA
Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma.
- Status
- UNKNOWN
- Phase
- PHASE4